NP90219b Leuprorelin (Prostap(r))

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-r6ebe6-0000781898-2024-11-05T00:00:00Z",
    "date": "2024-11-05T00:00:00Z",
    "ocid": "ocds-r6ebe6-0000781898",
    "initiationType": "tender",
    "parties": [
        {
            "id": "org-9",
            "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)",
            "identifier": {
                "legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)"
            },
            "address": {
                "streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent",
                "locality": "Edinburgh",
                "region": "UKM",
                "postalCode": "EH12 9EB"
            },
            "contactPoint": {
                "name": "Zenab Ghazali",
                "email": "zenab.ghazali@nhs.scot",
                "telephone": "+44 7977806098",
                "url": "http://"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "classifications": [
                    {
                        "id": "Body governed by public law",
                        "scheme": "TED_CA_TYPE"
                    },
                    {
                        "id": "07",
                        "description": "Health",
                        "scheme": "COFOG"
                    }
                ],
                "url": "http://www.nss.nhs.scot/browse/procurement-and-logistics"
            }
        },
        {
            "id": "org-27",
            "name": "Takeda UK Limited",
            "identifier": {
                "legalName": "Takeda UK Limited"
            },
            "address": {
                "streetAddress": "1 Kingdom Street",
                "locality": "London",
                "region": "UKM",
                "postalCode": "W2 6BD"
            },
            "contactPoint": {
                "telephone": "+44 7500578049"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "large",
                "url": "http://"
            }
        },
        {
            "id": "org-11",
            "name": "Sheriff Court House",
            "identifier": {
                "legalName": "Sheriff Court House"
            },
            "address": {
                "streetAddress": "27 Chambers Street",
                "locality": "Edinburgh",
                "postalCode": "EH1 1LB"
            },
            "contactPoint": {
                "email": "edinburgh@scotcourts.gov.uk",
                "telephone": "+44 1312252525",
                "url": "http://"
            },
            "roles": [
                "reviewBody"
            ]
        }
    ],
    "buyer": {
        "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)",
        "id": "org-9"
    },
    "tender": {
        "id": "ocds-r6ebe6-0000781898",
        "title": "NP90219b Leuprorelin (Prostap(r))",
        "description": "The supply of Leuprorelin (Prostap(r)) to NHS Scotland.",
        "status": "complete",
        "items": [
            {
                "id": "1",
                "additionalClassifications": [
                    {
                        "id": "33600000",
                        "scheme": "CPV"
                    }
                ],
                "deliveryLocation": {
                    "description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
                },
                "deliveryAddresses": [
                    {
                        "region": "UKM"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "procurementMethod": "limited",
        "procurementMethodDetails": "Award procedure without prior publication of a call for competition",
        "procurementMethodRationale": "This VEAT Notice is to advise the need for modification to meet the additional demands of the Scottish Health and Social Care sector during the Covid-19 pandemic and associated recovery, to maintain supply and remove unnecessary disruption from the Authority at this time in line with Regulation 72(1)(b) of the Public Contracts (Scotland) Regulations 2015.",
        "mainProcurementCategory": "goods",
        "documents": [
            {
                "id": "NOV517682",
                "documentType": "awardNotice",
                "title": "NP90219b Leuprorelin (Prostap(r))",
                "description": "The supply of Leuprorelin (Prostap(r)) to NHS Scotland.",
                "url": "https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=NOV517682",
                "format": "text/html"
            }
        ],
        "lots": [
            {
                "id": "1",
                "description": "The Framework Agreement is for the supply of Leuprorelin (Prostap(r)) to NHS Scotland. The Framework Agreement has been awarded as a single supplier framework agreement to one (1) Framework Participant. The Framework Participant is required to supply Goods to the designated delivery points throughout Scotland for use by Participating Authorities.",
                "status": "complete",
                "hasOptions": false
            }
        ],
        "coveredBy": [
            "GPA"
        ],
        "procurementMethodRationaleClassifications": [
            {
                "id": "D_OUTSIDE_SCOPE",
                "description": "The procurement falls outside the scope of application of the directive"
            }
        ],
        "techniques": {
            "hasFrameworkAgreement": true
        },
        "classification": {
            "id": "33600000",
            "scheme": "CPV"
        },
        "reviewDetails": "The notification will incorporate a 'standstill period' of a minimum of 10 clear calendar days (or a minimum of 15 if the communication method used is not electronic) between the date on which the Authority despatches the VEAT notice and the date on which the Authority proposes to conclude the relevant framework agreement. The bringing of court proceedings against the authority during the standstill period will automatically continue the prohibition on entering into the framework agreement until the court proceedings are determined, discontinued or disposed of, or the court, by interim order, brings to an end the prohibition. The remedies that may be awarded by the courts before the framework agreement has been entered into include the setting aside of the decision to award the framework agreement to the winning tenderer. The bringing of court proceedings against the authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.",
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        }
    },
    "awards": [
        {
            "id": "NP90219b",
            "suppliers": [
                {
                    "id": "org-27",
                    "name": "Takeda UK Limited"
                }
            ],
            "relatedLots": [
                "1"
            ]
        }
    ],
    "contracts": [
        {
            "id": "NP90219b",
            "awardID": "NP90219b",
            "status": "active",
            "value": {
                "amount": 105383,
                "currency": "GBP"
            },
            "dateSigned": "2024-11-04T00:00:00Z"
        }
    ],
    "language": "EN",
    "relatedProcesses": [
        {
            "id": "1",
            "relationship": [
                "planning"
            ],
            "scheme": "EU-OJ",
            "identifier": "2024/S 000-003019"
        }
    ],
    "description": "The estimated value of the Framework Agreement referred to in Section II.1.7 and V.2.4 covers the twelve (12) month duration of the proposed modification period of the Framework Agreement. (SC Ref:781898)",
    "links": [
        {
            "rel": "canonical",
            "href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000781898"
        }
    ],
    "noticetype": "OJEU - F15 - Voluntary Ex Ante Transparency Notice"
}